Clinical trial
Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in Kenya : The ASCEND Trial
NCT07545746 is registered in ClinicalTrials.gov with UNC Lineberger Comprehensive Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in Kenya : The ASCEND Trial
- Lead sponsor
- UNC Lineberger Comprehensive Cancer Center
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- September 30, 2026
- Completion date
- March 31, 2028
- Enrollment
- 140 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
cervical intraepithelial neoplasia grade 1, cervical intraepithelial neoplasia grade 2/3, cervical intraepithelial neoplasia grade 3, cervix cancer, cin, cin1, cin2, cin3, hiv infections, hpv infection